Tiger Medical Group

Tigermed is a China-founded, globally operating contract research organization focused on clinical development and related outsourced services for the biopharmaceutical and medical device industries. The company provides full-service support across preclinical development, clinical operations, biometrics, regulatory affairs, pharmacovigilance, central laboratory services, imaging, SMO services, and real-world evidence. It supports sponsors developing small molecules, biologics, cell and gene therapies, vaccines, rare disease products, and medical devices. Tigermed is publicly listed in both Shenzhen and Hong Kong and has built a broad international footprint through organic expansion and subsidiaries. For a biotech analyst, Tigermed is best understood as a diversified CRO and clinical development services platform rather than a therapeutics developer with an internal drug pipeline.